Main Navigation
Mercia
Ventures
Debt
Private equity
Contact us
About us
Investment strategies
Investor area
PLC
EIS
VCT
Contact us
Audience
|
Change
Ventures
Debt
Private equity
Contact us
About us
About us
Our history
Our vision and values
University partnerships
Team
Careers
Portfolio
Sustainability
Strategies
Our investment strategy
Our funds
Strategic assets
Property development finance
EIS & VCT
For shareholders
Share price
Board of directors
Financial reports & presentations
Regulatory news
Corporate governance
AIM Rule 26
Organisational structure
Annual Report
VCT
Northern Venture Trust
Northern 2 VCT
Northern 3 VCT
Insights & Research
Hub
Ventures
Debt
Private equity
Contact us
About us
Investment strategies
Investor area
PLC
EIS
VCT
Contact us
About us
About us
Our history
Our vision and values
University partnerships
Team
Careers
Portfolio
Sustainability
Strategies
Our investment strategy
Our funds
Strategic assets
Property development finance
EIS & VCT
For shareholders
Share price
Board of directors
Financial reports & presentations
Regulatory news
Corporate governance
AIM Rule 26
Organisational structure
Annual Report
VCT
Northern Venture Trust
Northern 2 VCT
Northern 3 VCT
Insights & Research
Hub
test documents
Mercia acquires Enterprise Ventures Group Limited
View
Oxford Genetics becomes latest emerging star to receive direct investment from Mercia Technologies
View
2016 – A year of growth as Mercia’s team strengthens
View
Drugs, development and discovery: Why the competition isn’t a patch on Medherant.
View
Mercia Fund Management makes First Scottish investment into world-renowned solid particle technology from University of Edinburgh
View
Fractured Space breaks half a million users for Edge Case Games
View
UK start-up develops world’s only pure Zika extract in fight against pandemic
View
AP&T first in the world to produce a production line for hot formed aluminium
View
WATCH: A year in review – Why 2015 was a year of growth for Mercia
View
Abzena signs significant licence deal for ThioBridge™ ADC linker technology with US biotech partner
View
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
Next
Loading...
Loading...
Disclaimer
Which of these options best describes you?
Please wait...
Disclaimers
Which of these options best describes you?
Please wait...
Loading...
Loading...
Disclaimer
Which of these options best describes you?
Please wait...
Disclaimers
Which of these options best describes you?
Please wait...